Mesalazine toxicity
Honeybourne, D.
Bmj 308(6927): 533-534
1994
ISSN/ISBN: 0959-8138 PMID: 8166873 Document Number: 436197
Document emailed within 1 workday
Related Documents
Romero, A.; Grau, M.T.; Villamayor, F.; Sacristán, A.; Ortiz, J.A. 1997: Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity Arzneimittel-Forschung 47(4a): 504-510Seror, P. 2000: Thrombopenia in treatment with mesalazine Presse Medicale 29(27): 1510-1511
Desmeules, J.; Vogt, N.; Loizeau, S.; Angelillo-Scherrer, A.; Dayer, P. 1994: Recurrent pericarditis induced by mesalazine (5-ASA) Therapie 49(4): 359-361
2011: Mesalazine. Now authorised for children, but no suitable form Prescrire International 20(119): 208
Vree, T.B.; Dammers, E.; Exler, P.S.; Sörgel, F.; Bondesen, S.; Maes, R.A. 2000: Liver and gut mucosa acetylation of mesalazine in healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 38(11): 514-522
Loizeau, E. 1995: Ulcerative colitis and pericarditis. the role of mesalazine hypersensitivity Revue Medicale de la Suisse Romande 115(11): 935-938
Steinhart, A.H.; Hemphill, D.; Greenberg, G.R. 1994: Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis American Journal of Gastroenterology 89(12): 2116-2124
Sánchez-Marín, B.; Grasa, J.M. 2004: Thrombosis of the superior sagittal sinus in an infant: secondary to prolonged exposure to mesalazine? Revista de Neurologia 38(2): 200
Wakefield, A.J.; Hudson, M.; Pounder, R.E. 1995: Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease Advances in Experimental Medicine and Biology 371b: 1307-1311
Tromm, A.; Griga, T.; May, B. 1999: Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties Hepato-Gastroenterology 46(30): 3124-3135
Sinico, R.A.; Sabadini, E.; Maresca, A.M. 2006: Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn's disease and sclerosing cholangitis Clinical and Experimental Rheumatology 24(2 Suppl 41: S104
Kanisawa, M.; Suzuki, S.; Kozuka, Y.; Yamazaki, M. 1977: Histopathological studies on the toxicity of ochratoxin A in rats. I. Acute oral toxicity Toxicology and Applied Pharmacology 42(1): 55-64
Morrow, D.H. 1970: Anesthesia and digitalis toxicity. VI. Effect of barbiturates and halothane on digoxin toxicity Anesthesia and Analgesia 49(2): 305-309
Ono, A. 2010: Perspective of predictive toxicity assessment of in vivo repeated dose toxicity using structural activity relationship Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 128: 44-49
Xu, L.; Zhang, Q.-l.; Gao, F.-p.; Nie, J.-s.; Niu, Q. 2010: Cell toxicity assessment methodologies applied in the study of the toxicity of nano-alumina to nerve cells Zhonghua Yu Fang Yi Xue Za Zhi 44(9): 785-789
Matsuzaki, M.; Sekino, M.; Fukushima, M.; Yoshida, A.; Asano, M. 1976: Studies on the toxicity of fusaric acid-Ca. II. Chronic toxicity in rats Japanese Journal of Antibiotics 29(5): 478-490
Tauchi, K.; Kawanishi, H.; Igarashi, N.; Maeda, Y.; Maeyama, Y.; Ebino, K.; Suzuki, K.; Imamichi, T. 1979: Studies on the toxicity of cefadroxil (S-578). II. Subacute toxicity in rats Japanese Journal of Antibiotics 32(12): 1233-1257
Flaherty, B.; Krenzelok, E.P. 1997: Neonatal lithium toxicity as a result of maternal toxicity Veterinary and Human Toxicology 39(2): 92-93
Brooks, P.M.; Day, R.O. 1995: Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders Journal of Rheumatology 22(5): 998-999
Koeda, T.; Odaki, M.; Hisamatsu, T.; Sasaki, H.; Yokota, M. 1973: Toxicity of 3',4'-dideoxykanamycin B. 3. Chronic toxicity in rats and dogs Japanese Journal of Antibiotics 26(3): 247-261